An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice
- PMID:19129426
- DOI: 10.1124/mol.108.052852
An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice
Abstract
Ghrelin is a 28-amino acid peptide secreted mainly by the stomach. Acyl-ghrelin, which binds to and activates the growth hormone secretagogue receptor type 1a (GHS-R1a), is considered to be the active form for its orexigenic effects. It has been demonstrated that peripheral administration of ghrelin stimulates food intake and adiposity in rodents and humans. Accordingly, different approaches to antagonize ghrelin/GHS-R1a signaling have been pursued for the treatment of obesity. In the present study, we generated and characterized high-affinity anti-acyl ghrelin-specific monoclonal antibodies (mAbs). In vitro, the lead mAb (33A) displayed specific binding to acyl-ghrelin, with an estimated K(d) value < 100 pM. In recombinant receptor cell-based assays, 33A dose-dependently inhibited the ghrelin-mediated calcium signal, with an IC(50) of approximately 3.5 nM. In vivo, ghrelin dose-dependently stimulated food intake in mice, and this effect was fully blocked by a single injection of 33A. In a 4-week chronic study, 33A was shown to effectively bind to endogenous acyl-ghrelin; however, long-term administration of 33A did not affect food intake or body weight gain in a mouse model of diet-induced obesity. Our results indicate that peripheral neutralization of ghrelin can suppress appetite stimulated by a transient surge in ghrelin levels. The lack of long-term effects on body weight control by 33A suggests that compensatory mechanisms may contribute to the regulation of energy balance.
Similar articles
- Intestinal Acyl-CoA synthetase 5 (ACSL5) deficiency potentiates postprandial GLP-1 & PYY secretion, reduces food intake, and protects against diet-induced obesity.Griffin JD, Zhu Y, Reeves A, Buhman KK, Greenberg AS.Griffin JD, et al.Mol Metab. 2024 May;83:101918. doi: 10.1016/j.molmet.2024.101918. Epub 2024 Mar 16.Mol Metab. 2024.PMID:38499083Free PMC article.
- Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.Elwenspoek MM, Thom H, Sheppard AL, Keeney E, O'Donnell R, Jackson J, Roadevin C, Dawson S, Lane D, Stubbs J, Everitt H, Watson JC, Hay AD, Gillett P, Robins G, Jones HE, Mallett S, Whiting PF.Elwenspoek MM, et al.Health Technol Assess. 2022 Oct;26(44):1-310. doi: 10.3310/ZUCE8371.Health Technol Assess. 2022.PMID:36321689Free PMC article.
- In Vitro and In Vivo Characterization of Novel Stable Peptidic Ghrelin Analogs: Beneficial Effects in the Settings of Lipopolysaccharide-Induced Anorexia in Mice.Holubová M, Blechová M, Kákonová A, Kuneš J, Železná B, Maletínská L.Holubová M, et al.J Pharmacol Exp Ther. 2018 Sep;366(3):422-432. doi: 10.1124/jpet.118.249086. Epub 2018 Jun 18.J Pharmacol Exp Ther. 2018.PMID:29914876
- Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.Wilson R, Godfrey CM, Sears K, Medves J, Ross-White A, Lambert N.Wilson R, et al.JBI Database System Rev Implement Rep. 2015 Oct;13(10):146-55. doi: 10.11124/jbisrir-2015-2150.JBI Database System Rev Implement Rep. 2015.PMID:26571290
- Ghrelin gene products and the regulation of food intake and gut motility.Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A.Chen CY, et al.Pharmacol Rev. 2009 Dec;61(4):430-81. doi: 10.1124/pr.109.001958.Pharmacol Rev. 2009.PMID:20038570Review.
Cited by
- Naringenin Decreases Retroperitoneal Adiposity and Improves Metabolic Parameters in a Rat Model of Western Diet-Induced Obesity.López-Almada G, Domínguez-Avila JA, Robles-Sánchez RM, Arauz-Cabrera J, Martínez-Coronilla G, González-Aguilar GA, Salazar-López NJ.López-Almada G, et al.Metabolites. 2025 Feb 8;15(2):109. doi: 10.3390/metabo15020109.Metabolites. 2025.PMID:39997735Free PMC article.
- Regulation of food intake: the gastric X/A-like endocrine cell in the spotlight.Stengel A, Taché Y.Stengel A, et al.Curr Gastroenterol Rep. 2009 Dec;11(6):448-54. doi: 10.1007/s11894-009-0069-4.Curr Gastroenterol Rep. 2009.PMID:19903420Free PMC article.Review.
- Ghrelin and ghrelin receptor modulation of psychostimulant action.Wellman PJ, Clifford PS, Rodriguez JA.Wellman PJ, et al.Front Neurosci. 2013 Sep 25;7:171. doi: 10.3389/fnins.2013.00171.Front Neurosci. 2013.PMID:24093007Free PMC article.Review.
- LCN2 blockade mitigating metabolic dysregulation and redefining appetite control in type 2 diabetes.Ernesto CS, Laura SD, Obed PI, David AR, Eloy GJ, Lilia GA.Ernesto CS, et al.Metab Brain Dis. 2025 Jan 14;40(1):97. doi: 10.1007/s11011-024-01454-0.Metab Brain Dis. 2025.PMID:39808380Free PMC article.
- Immunization against active ghrelin using virus-like particles for obesity treatment.Andrade S, Pinho F, Ribeiro AM, Carreira M, Casanueva FF, Roy P, Monteiro MP.Andrade S, et al.Curr Pharm Des. 2013;19(36):6551-8. doi: 10.2174/13816128113199990506.Curr Pharm Des. 2013.PMID:23859551Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical